EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieÄquivalenzstudieRandomisierte kontrollierte Studie

Drug-Coated Balloon Angioplasty vs Drug-Eluting Stents in Noncomplex Coronary Bifurcation Lesions

Bin Zhu, Fei Li, Jianzheng Liu, Likun Ma, Feng Yang, Zheng Ji, Hua Wang, Yanqing Wu, Zhenfei Fang, Jingyu Zhou, Haokao Gao, Tao Hu und 17 weitere

JACC: Cardiovascular Interventions · 2026-04 · 19 (8) · 943-957

DOI: 10.1016/j.jcin.2026.02.009 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JACC: Cardiovascular Interventions, 2026-04. Verfasst von Bin Zhu und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Coronary, Drug-Eluting Stents, Paclitaxel, Coronary Artery Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Drug-coated balloons (DCBs) are attractive for treating de novo coronary lesions, especially when involving bifurcations; however, their efficacy compared with drug-eluting stents (DES) remains uncertain. OBJECTIVES: The aim of this study was to assess the prognosis of DCBs vs DES in patients with noncomplex bifurcation and nonbifurcation lesions. METHODS: This was a prespecified subgroup analysis of the REC-CAGEFREE I (Paclitaxel-Coated Balloon for Treatment of De-Novo Non-Complex Coronary Artery Lesions) trial, which was an investigator-initiated, noninferiority trial conducted at 43 sites in China that randomized 2,272 participants to paclitaxel-coated balloons (the DCB group) or sirolimus-eluting stents (the DES group) for the treatment of de novo lesions, regardless of vessel diameter. The primary outcome was a device-oriented composite endpoint (DoCE) at 24 months. Participants were stratified according to the presence vs absence of bifurcation, and inverse probability of treatment weighting (IPTW) was performed to adjust for between-group imbalances. RESULTS: A total of 2,257 of 2,272 participants (99.3%) with available angiographic results were included. At 24 months, the DoCE had occurred in 46 of 773 patients in the bifurcation group (6.0%) and 64 of 1,484 patients in the nonbifurcation group (4.3%) (HRIPTW: 1.39; 95% CI: 0.87-2.21; P = 0.164). Of the 798 bifurcation lesions, 719 (90.1%) had DCB or DES treatment in the main vessel. A significant interaction for the DoCE was observed between bifurcation or nonbifurcation and assigned treatment (Pinteraction = 0.031). In the nonbifurcation group, the DoCE occurred in 46 of 735 patients with DCBs (6.3%) and 18 of 749 (2.4%) with DES (HRIPTW: 2.67; 95% CI: 1.64-4.33; P < 0.001); the in bifurcation group, the DoCE occurred in 26 of 394 patients with DCBs (6.7%) and 20 of 379 (5.3%) with DES (HRIPTW: 1.03; 95% CI: 0.53-2.01; P = 0.934). CONCLUSIONS: DCBs were associated with a numerically comparable risk for DoCE compared with DES in noncomplex bifurcations at 2 years. However, these findings should be interpreted as hypothesis generating only. (Paclitaxel-Coated Balloon for Treatment of De-Novo Non-Complex Coronary Artery Lesions; NCT04561739).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angioplasty, Balloon, CoronaryDrug-Eluting StentsPaclitaxelCoronary Artery DiseaseCardiovascular AgentsCoated Materials, BiocompatibleCardiac CathetersSirolimusHumansTime FactorsTreatment OutcomeProsthesis DesignFemaleAgedChinaMaleRisk FactorsMiddle Aged

Stichwörter der Autor:innen

coronary bifurcation lesionsdrug-coated balloondrug-eluting stent(s)

Substanzen

PaclitaxelCardiovascular AgentsCoated Materials, BiocompatibleSirolimus

Autor:innen und Institutionen

  • Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Department of Cardiology, The First Affiliated Hospital of USTC, Hefei, China.
  • Department of Cardiology, The First Hospital of Kunming, Kunming, China.
  • Department of Cardiology, Tangshan Workers Hospital, Tangshan, China.
  • Department of Cardiology, West China Hospital Sichuan University, Chengdu, China.
  • Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.

Zitieren

APA

Zhu, B., Li, F., Liu, J., Ma, L., Yang, F., Ji, Z., Wang, H., Wu, Y., Fang, Z., Zhou, J., Gao, H., Hu, T., Sun, D., Wang, Q., Jiang, H., Fu, G., Zhang, R., He, X., Xu, X., …, & REC-CAGEFREE I Investigators (2026). Drug-Coated Balloon Angioplasty vs Drug-Eluting Stents in Noncomplex Coronary Bifurcation Lesions. JACC: Cardiovascular Interventions, 19(8), 943-957. https://doi.org/10.1016/j.jcin.2026.02.009

Vancouver

Zhu B, Li F, Liu J, Ma L, Yang F, Ji Z, et al. Drug-Coated Balloon Angioplasty vs Drug-Eluting Stents in Noncomplex Coronary Bifurcation Lesions. JACC: Cardiovascular Interventions. 2026;19(8):943-957. doi:10.1016/j.jcin.2026.02.009

BibTeX
@article{Zhu2026,
  author = {Zhu, Bin and Li, Fei and Liu, Jianzheng and Ma, Likun and Yang, Feng and Ji, Zheng and Wang, Hua and Wu, Yanqing and Fang, Zhenfei and Zhou, Jingyu and Gao, Haokao and Hu, Tao and Sun, Dongdong and Wang, Qiong and Jiang, Hong and Fu, Guotao and Zhang, Ruining and He, Xingqiang and Xu, Xiaoming and Jiang, Zhiwei and Xia, Jielai and Wang, Duolao and Capodanno, Davide and Onuma, Yoshinobu and Serruys, Patrick W and Garg, Scot and Tao, Ling and Gao, Chao and REC-CAGEFREE I Investigators, REC-CAGEFREE I Investigators},
  title = {Drug-Coated Balloon Angioplasty vs Drug-Eluting Stents in Noncomplex Coronary Bifurcation Lesions},
  journal = {JACC: Cardiovascular Interventions},
  year = {2026},
  volume = {19},
  number = {8},
  pages = {943--957},
  doi = {10.1016/j.jcin.2026.02.009}
}
Kostenlos starten →